Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3901931017 | Product containing tazemetostat in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3901932012 | Tazemetostat-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tazemetostat-containing product in oral dose form | Is a | Tazemetostat-containing product | true | Inferred relationship | Some | ||
| Tazemetostat-containing product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tazemetostat-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
| Tazemetostat-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Tazemetostat-containing product in oral dose form | Has active ingredient | Tazemetostat | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tazemetostat only product in oral dose form | Is a | True | Tazemetostat-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
FHIR